Kovitz Investment Group Partners
GSK icon

Kovitz Investment Group Partners’s GSK GSK Stock Holding History

Kovitz Investment Group Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-24,869
Closed -$1.07M – 807
2025
Q3 		$1.07M Buy
24,869
+2,875
+13% +$112K ﹤0.01% 830
2025
Q2 		$845K Sell
21,994
-1,292
-6% -$49.4K ﹤0.01% 840
2025
Q1 		$902K Buy
23,286
+1,706
+8% +$62.5K ﹤0.01% 767
2024
Q4 		$730K Buy
21,580
+1,556
+8% +$56K ﹤0.01% 796
2024
Q3 		$718K Buy
20,024
+6,383
+47% +$261K 0.01% 699
2024
Q2 		$525K Sell
13,641
-1,948
-12% -$81.9K ﹤0.01% 647
2024
Q1 		$668K Buy
+15,589
New +$643K 0.01% 464

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.3B AUM 42.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return